Keep up with the latest trends and applications of AI in healthcare from the experts at AllazoHealth. Find best practices, tools, and breakthroughs in using artificial intelligence to drive meaningful engagement and outcomes for patient support programs and pharmaceutical marketing.
NEW YORK, NY and TAMPA, FL (June 12, 2019) – CSS Health, a comprehensive medication management, adherence and quality improvement company focused on improving population health, and AllazoHealth, an artificial intelligence (AI) and predictive analytics…
Read moreNew York, NY (April 23, 2019) – AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Dr. Linda Schultz has joined the company as…
Read moreNEW YORK, NY and FORT MILL, SC (March 4, 2019) – Lash Group, a patient support services company and a part of AmerisourceBergen, and AllazoHealth, an artificial intelligence (AI) and predictive analytics company focused on…
Read moreAllazoHealth and Large Regional Payer Validate Use of Artificial Intelligence in Improving Medication Adherence with Randomized Controlled Study AllazoHealth has co-published a randomized controlled study with Blue Cross Blue Shield of North Carolina. The study…
Read moreNew York, NY – AllazoHealth, the AI and predictive analytics company focused on predicting and changing patient behaviors through precision engagement, announced today that Steve Cohan will be joining the company’s Advisory Board. Prior to joining…
Read moreNew York, NY – AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Bill Grambley has joined the company as Chief Operating Officer. Prior…
Read moreNew York, NY – AllazoHealth, the leading AI and predictive analytics company focused on improving medication adherence, announced today that Bill Moult will be appointed to the Board of Directors. Prior to joining AllazoHealth’s board, Mr.…
Read moreThe panel focused on exploring how new, innovative technologies are improving medication adherence and clinical outcomes for patients with depression. New York, NY – On May 6th, AllazoHealth CEO, Clifford Jones, appeared at this year’s American Psychiatric…
Read moreNew York, NY (January 9, 2018) – AllazoHealth, the industry leader in optimizing medication adherence programs through artificial intelligence (AI), today announced that its AllazoEngine™ platform was named the winner of the Data Analytics &…
Read moreAllazoHealth and Large Regional Payer Validate Use of Artificial Intelligence in Improving Medication Adherence with Randomized Controlled Study PRESS RELEASE, October 30, 2017 — AllazoHealth has co-published a randomized controlled study with Blue Cross Blue…
Read more